etoposide has been researched along with methylselenic acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Encío, I; Garnica, P; Palop, JA; Plano, D; Sanmartín, C | 1 |
| Hu, H; Ip, C; Jiang, C; Lü, J; Rustum, YM | 1 |
| Calvo, A; de las Rivas, J; Gonzalez-Moreno, O; Nguewa, P; Segura, V; Serrano, D | 1 |
3 other study(ies) available for etoposide and methylselenic acid
| Article | Year |
|---|---|
Combined Acylselenourea-Diselenide Structures: New Potent and Selective Antitumoral Agents as Autophagy Activators.
Topics: | 2018 |
Methylseleninic acid potentiates apoptosis induced by chemotherapeutic drugs in androgen-independent prostate cancer cells.
Topics: Androgens; Antineoplastic Agents, Phytogenic; Apoptosis; Camptothecin; Caspases; Drug Therapy, Combination; Enzyme Activation; Etoposide; Humans; JNK Mitogen-Activated Protein Kinases; Male; Organoselenium Compounds; p38 Mitogen-Activated Protein Kinases; Paclitaxel; Phosphorylation; Poly(ADP-ribose) Polymerases; Prostatic Neoplasms; Tumor Cells, Cultured | 2005 |
Methylseleninic acid enhances the effect of etoposide to inhibit prostate cancer growth in vivo.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Docetaxel; Dose-Response Relationship, Drug; Drug Synergism; Etoposide; Gene Expression; Gene Expression Profiling; Humans; Male; Metabolic Networks and Pathways; Mice; Mice, Nude; Oligonucleotide Array Sequence Analysis; Organoselenium Compounds; Prostatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Taxoids; Xenograft Model Antitumor Assays | 2007 |